Vertigo, a subjective sensation of movement, is a frequently encountered symptom in clinical practice. It poses a diagnostic challenge due to its multifactorial etiology, which necessitates a comprehensive clinical approach for appropriate management.
Vertigo is not a disease but rather a symptom of various underlying conditions. It is often the result of a mismatch of sensory inputs from the vestibular, visual, and somatosensory systems. This can be due to peripheral vestibular disorders such as benign paroxysmal positional vertigo, Meniere's disease, or central causes like stroke and multiple sclerosis.
Assessment of a patient with vertigo begins with a detailed history and physical examination. Key elements to inquire include the onset, duration, and nature of vertigo, associated symptoms, and triggering factors. Physical examination should include a thorough neurological and otologic examination, along with specific tests like the Dix-Hallpike maneuver and head impulse test.
Based on the clinical evaluation, further investigations may be needed. These could include audiometry, vestibular function tests, and neuroimaging. The choice of investigations depends on the suspected underlying etiology. For instance, magnetic resonance imaging is warranted in cases suspected of central vertigo.
Management of vertigo is tailored according to the underlying cause. It may include medications, vestibular rehabilitation exercises, or surgical interventions. Patient education and reassurance also play a critical role in managing this distressing symptom.
Vertigo is a complex symptom requiring a meticulous and systematic approach for accurate diagnosis and effective management. As healthcare professionals, understanding the pathophysiology, clinical evaluation, diagnostic approach, and management strategies of vertigo is pivotal in providing optimal patient care.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation